ensembl_id string | gene string | gene_description string | uniprot list | chromosome string | position string | evidence string | hpa_evidence string | uniprot_evidence string | nextprot_evidence string | antibodies list | gene_synonyms list | protein_classes list | biological_processes list | molecular_functions list | disease_involvement list | subcellular_main_locations list | subcellular_additional_locations list | secretome_locations list | secretome_functions list | reliability_if string | reliability_ih string | reliability_mouse_brain string | interactions float64 | ccd_protein string | ccd_transcript string | blood_expression_cluster string | brain_expression_cluster string | cell_line_expression_cluster string | single_cell_expression_cluster string | tissue_expression_cluster string | rna_tissue_specificity string | rna_tissue_distribution string | rna_tissue_specificity_score float64 | rna_cell_line_specificity string | rna_cell_line_distribution string | rna_cell_line_specificity_score float64 | rna_cancer_specificity string | rna_cancer_distribution string | rna_cancer_specificity_score float64 | rna_single_cell_type_specificity string | rna_single_cell_type_distribution string | rna_single_cell_type_specificity_score float64 | rna_blood_cell_specificity string | rna_blood_cell_distribution string | rna_blood_cell_specificity_score float64 | prognostic_cancer_count int64 | validated_prognostic_cancer_count int64 | potential_prognostic_cancer_count int64 | favorable_prognostic_cancers list | unfavorable_prognostic_cancers list | prognostic_cancers list | source_row_index int64 | split_bucket int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG00000109851 | DBX1 | Developing brain homeobox 1 | [
"A6NMT0"
] | 11 | 20156155-20160475 | Evidence at protein level | No human protein/transcript evidence | No human protein/transcript evidence | Evidence at protein level | [
"HPA039802"
] | [] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [] | [
"Developmental protein",
"DNA-binding"
] | [] | [] | [] | [] | [] | null | Uncertain | null | null | null | null | null | null | Cluster 33: Sarcoma - Muscle contraction | Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure | null | Not detected | Not detected | null | Group enriched | Detected in some | 16 | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,671 | 9 |
ENSG00000109854 | HTATIP2 | HIV-1 Tat interactive protein 2 | [
"Q9BUP3"
] | 11 | 20363685-20383782 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006417",
"HPA024321"
] | [
"CC3",
"FLJ26963",
"SDR44U1",
"TIP30"
] | [
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Host-virus interaction",
"Translation regulation"
] | [] | [
"Tumor suppressor"
] | [
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 6 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 28: Oligodendrocytes - Mixed function | Cluster 7: Liver cancer - Metabolism | Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier | Cluster 77: Intestine - Digestion | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [] | [
"Breast Invasive Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 3,672 | 2 |
ENSG00000109861 | CTSC | Cathepsin C | [
"P53634"
] | 11 | 88265069-88359684 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB025364",
"HPA066610",
"HPA068434"
] | [
"DPP1",
"PALS",
"PLS"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Hydrolase",
"Protease",
"Thiol protease"
] | [
"Disease variant",
"Palmoplantar keratoderma"
] | [
"Vesicles"
] | [] | [
"Intracellular and membrane"
] | [
"Enzyme"
] | Supported | Enhanced | null | 9 | No | No | Cluster 10: Non-specific - Membrane trafficking | Cluster 20: Macrophages & Microglia - Immune response | Cluster 64: Connective tissue cells - ECM organization | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Bladder Urothelial Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,673 | 6 |
ENSG00000109881 | CCDC34 | Coiled-coil domain containing 34 | [
"Q96HJ3"
] | 11 | 27330827-27363234 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA037574"
] | [
"L15",
"NY-REN-41",
"RAMA3"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nuclear membrane",
"Nucleoli fibrillar center",
"Calyx",
"Mid piece"
] | [
"Connecting piece",
"Principal piece",
"End piece"
] | [] | [] | Approved | Uncertain | null | null | null | null | Cluster 16: Non-specific - Cell proliferation | Cluster 24: Neurons - Mixed function | Cluster 71: Lymphoma - Inflammatory response | Cluster 27: Non-specific - Cell proliferation | Cluster 56: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 4 | 2 | 3 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,674 | 6 |
ENSG00000109911 | ELP4 | Elongator acetyltransferase complex subunit 4 | [
"Q96EB1"
] | 11 | 31509755-31790324 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038572",
"HPA038573"
] | [
"C11orf19",
"PAXNEB"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"tRNA processing"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 8 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 15: Non-specific - Transcription | Cluster 30: Non-specific - Gene expression regulation | Cluster 7: Non-specific - Transcription | Cluster 27: Cerebellum - Synaptic function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Lung Squamous Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Lung Squamous Cell Carcinoma"
] | 3,676 | 1 |
ENSG00000109917 | ZPR1 | ZPR1 zinc finger | [
"O75312"
] | 11 | 116773799-116788039 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB022596",
"HPA030979"
] | [
"ZNF259"
] | [
"Disease related genes",
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Differentiation",
"mRNA processing",
"mRNA splicing"
] | [] | [
"Deafness",
"Dwarfism",
"Hypotrichosis"
] | [
"Vesicles"
] | [] | [] | [] | Approved | Uncertain | null | 2 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 14: Neurons - Synaptic function | Cluster 24: Non-specific - Unknown function | Cluster 73: Late spermatids - Spermiogenesis: Maturation | Cluster 39: Testis - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 4 | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,677 | 5 |
ENSG00000109919 | MTCH2 | Mitochondrial carrier 2 | [
"Q9Y6C9"
] | 11 | 47617315-47642607 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA038390"
] | [
"SLC25A50"
] | [
"Predicted membrane proteins",
"Transporters"
] | [
"Transport"
] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | Approved | null | 81 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 21: Non-specific - Metabolism | Cluster 24: Non-specific - Unknown function | Cluster 97: Non-specific - Cellular respiration | Cluster 31: Liver - Metabolism & Coagulation | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,678 | 6 |
ENSG00000109920 | FNBP4 | Formin binding protein 4 | [
"Q8N3X1"
] | 11 | 47716494-47767443 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039485",
"HPA040029"
] | [
"KIAA1014"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Supported | null | 3 | null | null | Cluster 22: Eosinophils - Transcription | Cluster 48: Non-specific - Mixed function | Cluster 56: Non-specific - Sensory perception | Cluster 102: Non-specific - Mixed function | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Rectum Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma",
"Rectum Adenocarcinoma"
] | 3,679 | 3 |
ENSG00000109927 | TECTA | Tectorin alpha | [
"O75443"
] | 11 | 121101243-121191490 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA018870"
] | [
"DFNA12",
"DFNA8",
"DFNB21"
] | [
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted membrane proteins",
"Predicted secreted proteins",
"Transporters"
] | [
"Hearing"
] | [] | [
"Deafness",
"Disease variant",
"Non-syndromic deafness"
] | [] | [] | [
"Secreted in other tissues"
] | [
"Other"
] | null | Approved | null | null | null | null | null | Cluster 1: Neurons - Mixed function | Cluster 54: Non-specific - Transcription | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | Cluster 48: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in some | null | Cancer enriched | Detected in single | 4 | Cancer enhanced | Detected in single | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,680 | 6 |
ENSG00000109929 | SC5D | Sterol-C5-desaturase | [
"O75845"
] | 11 | 121292681-121313410 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA066283",
"HPA070248"
] | [
"SC5DL"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted membrane proteins"
] | [
"Lipid biosynthesis",
"Lipid metabolism",
"Steroid biosynthesis",
"Steroid metabolism",
"Sterol biosynthesis",
"Sterol metabolism"
] | [
"Oxidoreductase"
] | [
"Disease variant"
] | [
"Nucleoplasm",
"Endoplasmic reticulum"
] | [
"Plasma membrane",
"Cytosol"
] | [] | [] | Approved | Enhanced | null | 2 | No | No | Cluster 30: Non-specific - DNA binding | Cluster 49: Hindbrain - Mixed function | Cluster 66: Non-specific - Mitochondria | Cluster 25: Hepatocytes - Plasma protein synthesis & secretion | Cluster 45: Liver - Metabolism & Coagulation | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Skin Cutaneous Melanoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Skin Cutaneous Melanoma"
] | 3,681 | 6 |
ENSG00000109943 | CRTAM | Cytotoxic and regulatory T cell molecule | [
"O95727"
] | 11 | 122838500-122872643 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"CD355"
] | [
"CD markers",
"Predicted membrane proteins"
] | [
"Adaptive immunity",
"Cell adhesion",
"Immunity"
] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 24: Non-specific - Transcription | Cluster 35: Non-specific - DNA binding | Cluster 59: Leukemia - T-cell receptor | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 71: Cerebellum - Nervous system development | Tissue enriched | Detected in some | 16 | Not detected | Not detected | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | 3,682 | 9 |
ENSG00000109971 | HSPA8 | Heat shock protein family A (Hsp70) member 8 | [
"P11142"
] | 11 | 123057489-123063230 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB002056",
"HPA052504"
] | [
"HSC70",
"HSC71",
"HSP73",
"HSPA10"
] | [
"Cancer-related genes",
"Enzymes",
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Autophagy",
"Host-virus interaction",
"mRNA processing",
"mRNA splicing",
"Stress response",
"Transcription",
"Transcription regulation"
] | [
"Chaperone",
"Hydrolase",
"Repressor"
] | [
"Cancer-related genes"
] | [
"Vesicles",
"Flagellar centriole",
"Annulus"
] | [
"Perinuclear theca",
"Calyx"
] | [] | [] | Supported | Uncertain | null | 697 | null | Yes | Cluster 9: T-regs - Cell cycle regulation | Cluster 21: Non-specific - Metabolism | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 20: Non-specific - Transcription regulation | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,685 | 8 |
ENSG00000109991 | P2RX3 | Purinergic receptor P2X 3 | [
"P56373"
] | 11 | 57338352-57372396 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA057776"
] | [
"P2X3"
] | [
"Predicted membrane proteins",
"Transporters"
] | [
"Ion transport",
"Transport"
] | [
"Ion channel",
"Ligand-gated ion channel",
"Receptor"
] | [] | [] | [] | [] | [] | null | Uncertain | null | null | null | null | null | null | Cluster 65: Non-specific - Unknown function | Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc | Cluster 35: Non-specific - Mixed function | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in some | 5 | Not detected | Not detected | null | Group enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,686 | 2 |
ENSG00000110002 | VWA5A | Von Willebrand factor A domain containing 5A | [
"O00534"
] | 11 | 124115404-124147721 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA037813",
"HPA037814",
"HPA061500"
] | [
"BCSC-1",
"LOH11CR2A"
] | [
"Predicted intracellular proteins"
] | [] | [] | [
"Tumor suppressor"
] | [
"Nucleoplasm"
] | [
"Nucleoli"
] | [] | [] | Enhanced | Uncertain | null | 3 | null | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 16: Thyroid cancer - Neuronal signaling | Cluster 58: Mast cells - Allergic inflammatory responses | Cluster 77: Intestine - Digestion | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 6 | Immune cell enriched | Detected in many | 5 | 1 | 0 | 1 | [
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Papillary Cell Carcinoma"
] | 3,687 | 8 |
ENSG00000110011 | DNAJC4 | DnaJ heat shock protein family (Hsp40) member C4 | [
"Q9NNZ3"
] | 11 | 64230278-64234286 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA011947"
] | [
"HSPF2",
"MCG18"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Chaperone"
] | [] | [] | [] | [] | [] | null | Uncertain | null | 5 | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 18: Non-specific - Mixed function | Cluster 35: RS4;11 - Unknown function | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 21: Testis - Mixed function | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 8 | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Papillary Cell Carcinoma"
] | 3,688 | 4 |
ENSG00000110013 | SIAE | Sialic acid acetylesterase | [
"Q9HAT2"
] | 11 | 124633113-124695707 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA038052",
"HPA038053"
] | [
"CSE-C",
"LSE",
"MGC87009",
"YSG2"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase",
"Serine esterase"
] | [
"Disease variant"
] | [] | [] | [
"Intracellular and membrane"
] | [
"Enzyme"
] | null | Approved | null | 2 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 44: Non-specific - Mixed function | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 54: Intestinal epithelial cells - Intestinal epi homeostasis & respiration | Cluster 76: Non-specific - Metabolism | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 3,689 | 5 |
ENSG00000110025 | SNX15 | Sorting nexin 15 | [
"Q9NRS6"
] | 11 | 65027439-65040572 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038955"
] | [] | [
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [] | [] | [
"Nucleoli",
"Cytosol"
] | [
"Vesicles",
"Plasma membrane"
] | [] | [] | Approved | Approved | null | 8 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 34: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 98: Neurons - Neurotransmission & signaling | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,690 | 7 |
ENSG00000110031 | LPXN | Leupaxin | [
"O60711"
] | 11 | 58526871-58578220 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043741",
"CAB046478",
"HPA061441"
] | [
"LDPL"
] | [
"Predicted intracellular proteins"
] | [
"Cell adhesion",
"Transcription",
"Transcription regulation"
] | [
"Activator"
] | [] | [
"Focal adhesion sites"
] | [
"Nuclear speckles",
"Cytosol"
] | [] | [] | Supported | Enhanced | null | 20 | No | No | Cluster 13: Non-specific - Mitochondria | Cluster 28: Oligodendrocytes - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Lung Adenocarcinoma"
] | [] | [
"Lung Adenocarcinoma"
] | 3,691 | 6 |
ENSG00000110042 | DTX4 | Deltex E3 ubiquitin ligase 4 | [
"Q9Y2E6"
] | 11 | 59171430-59208588 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA056760",
"HPA059294"
] | [
"KIAA0937",
"RNF155"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [
"Notch signaling pathway",
"Ubl conjugation pathway"
] | [
"Transferase"
] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | Approved | null | 2 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 30: White matter - Myelination | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 69: Urothelial cells - Basic cellular functions | Cluster 3: Oligodendrocytes - Myelination | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 2 | 0 | 2 | [
"Rectum Adenocarcinoma",
"Thyroid Carcinoma"
] | [] | [
"Rectum Adenocarcinoma",
"Thyroid Carcinoma"
] | 3,692 | 8 |
ENSG00000110046 | ATG2A | Autophagy related 2A | [
"Q2TAZ0"
] | 11 | 64894546-64917211 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA038715"
] | [
"BLTP4A",
"KIAA0404"
] | [
"Predicted intracellular proteins",
"Transporters"
] | [
"Autophagy",
"Lipid transport",
"Transport"
] | [] | [] | [
"Vesicles"
] | [
"Nucleoplasm"
] | [] | [] | Uncertain | Uncertain | null | 9 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 12: Non-specific - Vasculature | Cluster 24: Non-specific - Unknown function | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in many | 6 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Rectum Adenocarcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Rectum Adenocarcinoma"
] | 3,693 | 2 |
ENSG00000110047 | EHD1 | EH domain containing 1 | [
"Q9H4M9"
] | 11 | 64851642-64888296 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA049890",
"HPA049986",
"HPA066751",
"HPA067747"
] | [
"FLJ42622",
"FLJ44618",
"H-PAST",
"HPAST1",
"PAST1"
] | [
"Plasma proteins",
"Predicted intracellular proteins",
"Transporters"
] | [
"Cilium biogenesis/degradation",
"Protein transport",
"Transport"
] | [] | [] | [
"Plasma membrane"
] | [
"Primary cilium",
"Primary cilium transition zone"
] | [] | [] | Supported | Approved | null | 46 | null | null | Cluster 7: Non-specific - Innate immune response | Cluster 25: Non-specific - Transcription | Cluster 55: Lymphoma - Immune response | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 39: Testis - Nuclear processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 5 | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 3,694 | 1 |
ENSG00000110048 | OSBP | Oxysterol binding protein | [
"P22059"
] | 11 | 59574398-59615774 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039227",
"HPA043625"
] | [
"OSBP1"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Lipid transport",
"Transport"
] | [] | [] | [
"Golgi apparatus"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | Supported | Enhanced | null | 41 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 21: Non-specific - Metabolism | Cluster 24: Non-specific - Unknown function | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 3,695 | 6 |
ENSG00000110057 | UNC93B1 | Unc-93 homolog B1, TLR signaling regulator | [
"Q9H1C4"
] | 11 | 67991100-68004982 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038716",
"HPA038717",
"HPA042803"
] | [
"UNC93"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Adaptive immunity",
"Antiviral defense",
"Immunity",
"Innate immunity"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | 111 | No | No | Cluster 29: Non-specific - Unknown function | Cluster 43: Hindbrain - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 6: Plasmacytoid dendritic cells - Viral sensing & interferon response | Cluster 5: Spleen - Immune response | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 3 | 0 | 3 | [] | [
"Breast Invasive Carcinoma",
"Lung Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Lung Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 3,696 | 1 |
ENSG00000110060 | PUS3 | Pseudouridine synthase 3 | [
"Q9BZE2"
] | 11 | 125893485-125903221 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038040",
"HPA063802"
] | [
"DEG1",
"FKSG32"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"tRNA processing"
] | [
"Isomerase"
] | [
"Intellectual disability"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Uncertain | null | null | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 31: Non-specific - Transcription | Cluster 24: Non-specific - Unknown function | Cluster 17: Non-specific - RNA processing | Cluster 45: Liver - Metabolism & Coagulation | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Breast Invasive Carcinoma"
] | [] | [
"Breast Invasive Carcinoma"
] | 3,697 | 8 |
ENSG00000110063 | DCPS | Decapping enzyme, scavenger | [
"Q96C86"
] | 11 | 126304060-126350005 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039632",
"HPA058597"
] | [
"HINT-5",
"HINT5",
"HSL1",
"HSPC015"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing"
] | [
"Hydrolase"
] | [
"Disease variant",
"Intellectual disability"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Enhanced | null | 10 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 23: Choroid plexus - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 31: Liver - Metabolism & Coagulation | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [] | [
"Lung Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | 3,698 | 2 |
ENSG00000110066 | KMT5B | Lysine methyltransferase 5B | [
"Q4FZB7"
] | 11 | 68154863-68213852 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038509"
] | [
"CGI-85",
"SUV420H1"
] | [
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Myogenesis",
"Transcription",
"Transcription regulation"
] | [
"Chromatin regulator",
"Methyltransferase",
"Repressor",
"Transferase"
] | [
"Disease variant",
"Intellectual disability"
] | [
"Nucleoplasm",
"Nucleoli fibrillar center"
] | [
"Plasma membrane",
"Microtubules",
"Cytokinetic bridge",
"Mitotic spindle",
"Primary cilium",
"Centrosome",
"Basal body",
"Cytoplasmic bodies"
] | [] | [] | Supported | null | null | 4 | Yes | null | Cluster 45: Eosinophils - Unknown function | Cluster 55: Non-specific - Transcription | Cluster 24: Non-specific - Unknown function | Cluster 7: Non-specific - Transcription | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 3,699 | 8 |
ENSG00000110074 | FOXRED1 | FAD dependent oxidoreductase domain containing 1 | [
"Q96CU9"
] | 11 | 126269024-126278131 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039620",
"HPA046192"
] | [
"H17"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Electron transport",
"Respiratory chain",
"Transport"
] | [
"Oxidoreductase"
] | [
"Disease variant",
"Primary mitochondrial disease"
] | [
"Mitochondria"
] | [] | [] | [] | Supported | Uncertain | null | 4 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 24: Non-specific - Unknown function | Cluster 65: Non-specific - Cell growth & division | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 3,700 | 7 |
ENSG00000110075 | PPP6R3 | Protein phosphatase 6 regulatory subunit 3 | [
"Q5H9R7"
] | 11 | 68460731-68615334 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB017183",
"HPA038467",
"HPA038468"
] | [
"C11orf23",
"DKFZp781E17107",
"DKFZp781E2374",
"DKFZp781O2362",
"FLJ11058",
"FLJ43065",
"KIAA1558",
"MGC125711",
"MGC125712",
"PP6R3",
"SAP190",
"SAPL",
"SAPLa",
"SAPS3"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Plasma membrane",
"Cytosol"
] | [] | [] | [] | Enhanced | Supported | null | 30 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 55: Non-specific - Transcription | Cluster 24: Non-specific - Unknown function | Cluster 7: Non-specific - Transcription | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 5 | 0 | 5 | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 3,701 | 7 |
ENSG00000110076 | NRXN2 | Neurexin 2 | [
"P58401",
"Q9P2S2"
] | 11 | 64606174-64723197 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Cell adhesion"
] | [] | [] | [] | [] | [] | [] | null | null | null | null | null | null | null | Cluster 15: Non-specific - Transcription | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 109: Neurons - Neuronal signaling | Cluster 27: Cerebellum - Synaptic function | Tissue enriched | Detected in many | 8 | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Thyroid Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Thyroid Carcinoma"
] | 3,702 | 1 |
ENSG00000110077 | MS4A6A | Membrane spanning 4-domains A6A | [
"Q9H2W1"
] | 11 | 60172015-60184666 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA011391",
"HPA076623"
] | [
"CD20L3",
"MS4A6"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Receptor"
] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | Approved | null | 1 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 20: Macrophages & Microglia - Immune response | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Cancer enriched | Detected in some | 8 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in all | 8 | 0 | 0 | 0 | [] | [] | [] | 3,703 | 5 |
ENSG00000110079 | MS4A4A | Membrane spanning 4-domains A4A | [
"Q96JQ5"
] | 11 | 60185657-60318080 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA029323"
] | [
"CD20L1",
"MS4A4",
"MS4A7"
] | [
"Predicted membrane proteins"
] | [] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | Approved | null | 14 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 20: Macrophages & Microglia - Immune response | Cluster 47: Leukemia - Hemostasis | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 5 | 1 | 0 | 1 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | 3,704 | 3 |
ENSG00000110080 | ST3GAL4 | ST3 beta-galactoside alpha-2,3-sialyltransferase 4 | [
"Q11206"
] | 11 | 126355640-126440344 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA049827"
] | [
"CGS23",
"FLJ11867",
"NANTA3",
"SAT3",
"SIAT4",
"SIAT4C",
"STZ"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Lipid metabolism"
] | [
"Glycosyltransferase",
"Transferase"
] | [] | [] | [] | [
"Intracellular and membrane"
] | [
"Enzyme"
] | null | Approved | null | null | null | null | Cluster 41: Basophils - Unknown function | Cluster 30: White matter - Myelination | Cluster 69: Skin cancer - ECM organization | Cluster 39: Syncytiotrophoblasts - Placental homeostasis & endocrine signal | Cluster 4: Adrenal gland - Steroid metabolism | Low tissue specificity | Detected in all | null | Cancer enriched | Detected in all | 4 | Cancer enhanced | Detected in all | null | Group enriched | Detected in many | 4 | Group enriched | Detected in many | 4 | 1 | 0 | 1 | [] | [
"Lung Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | 3,705 | 2 |
ENSG00000110090 | CPT1A | Carnitine palmitoyltransferase 1A | [
"P50416"
] | 11 | 68754620-68844410 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA008835"
] | [
"CPT1",
"CPT1-L",
"L-CPT1"
] | [
"Disease related genes",
"Enzymes",
"FDA approved drug targets",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Fatty acid metabolism",
"Lipid metabolism",
"Transport"
] | [
"Acyltransferase",
"Transferase"
] | [
"Disease variant",
"FDA approved drug targets"
] | [
"Mitochondria"
] | [] | [] | [] | Supported | Supported | null | 12 | null | null | Cluster 41: Basophils - Unknown function | Cluster 42: Choroid plexus - Mitochondria | Cluster 7: Liver cancer - Metabolism | Cluster 54: Intestinal epithelial cells - Intestinal epi homeostasis & respiration | Cluster 77: Intestine - Digestion | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 3,706 | 4 |
ENSG00000110092 | CCND1 | Cyclin D1 | [
"P24385"
] | 11 | 69641156-69654474 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA027802",
"CAB080462"
] | [
"BCL1",
"D11S287E",
"PRAD1",
"U21B31"
] | [
"Cancer-related genes",
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Predicted intracellular proteins",
"Transporters"
] | [
"Cell cycle",
"Cell division",
"DNA damage",
"Transcription",
"Transcription regulation"
] | [
"Cyclin",
"Repressor"
] | [
"Cancer-related genes",
"FDA approved drug targets",
"Proto-oncogene"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Supported | null | 98 | Yes | No | Cluster 32: Basophils - Transcription | Cluster 42: Choroid plexus - Mitochondria | Cluster 64: Connective tissue cells - ECM organization | Cluster 100: Stratified epithelial cells - Barrier functions | Cluster 58: Skin - Keratinization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 3,707 | 6 |
ENSG00000110104 | CCDC86 | Coiled-coil domain containing 86 | [
"Q9H6F5"
] | 11 | 60842113-60851081 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041117",
"HPA041540"
] | [
"cyclon",
"MGC2574"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Host-virus interaction"
] | [] | [] | [
"Nucleoli",
"Nucleoli rim",
"Mitotic chromosome"
] | [
"Nucleoplasm"
] | [] | [] | Enhanced | Enhanced | null | 22 | Yes | No | Cluster 13: Non-specific - Mitochondria | Cluster 27: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 69: Parathyroid gland - Mixed function | Tissue enriched | Detected in all | 8 | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 4 | 1 | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,708 | 2 |
ENSG00000110107 | PRPF19 | Pre-mRNA processing factor 19 | [
"Q9UMS4"
] | 11 | 60890547-60906585 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB012448",
"HPA038051",
"HPA059070"
] | [
"hPSO4",
"NMP200",
"PRP19",
"PSO4",
"SNEV",
"UBOX4"
] | [
"Enzymes",
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"DNA damage",
"DNA repair",
"mRNA processing",
"mRNA splicing",
"Ubl conjugation pathway"
] | [
"Transferase"
] | [] | [
"Nuclear speckles"
] | [] | [] | [] | Enhanced | Supported | null | 197 | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 1: Neurons - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 2: Non-specific - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 2 | 1 | [] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,709 | 6 |
ENSG00000110108 | TMEM109 | Transmembrane protein 109 | [
"Q9BVC6"
] | 11 | 60914158-60923443 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA011785",
"HPA012101"
] | [
"MGC5508"
] | [
"Predicted membrane proteins",
"Transporters"
] | [
"Ion transport",
"Transport"
] | [
"Ion channel",
"Voltage-gated channel"
] | [] | [
"Nuclear membrane",
"Endoplasmic reticulum"
] | [
"Vesicles",
"Actin filaments"
] | [] | [] | Approved | Approved | null | 18 | null | null | Cluster 8: Plasmacytoid DCs - Unknown function | Cluster 42: Choroid plexus - Mitochondria | Cluster 24: Non-specific - Unknown function | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 12: Smooth muscle tissue - ECM organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,710 | 8 |
ENSG00000110148 | CCKBR | Cholecystokinin B receptor | [
"P32239"
] | 11 | 6259806-6272127 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA079548"
] | [] | [
"Cancer-related genes",
"FDA approved drug targets",
"G-protein coupled receptors",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"Cancer-related genes",
"FDA approved drug targets"
] | [
"Vesicles"
] | [
"Plasma membrane"
] | [] | [] | Uncertain | null | null | 7 | null | null | null | Cluster 53: Neurons - Mixed function | Cluster 34: Testis cancer - Unknown function | Cluster 97: Non-specific - Cellular respiration | Cluster 70: Non-specific - Protein processing | Group enriched | Detected in some | 33 | Group enriched | Detected in some | 6 | Cancer enriched | Detected in some | 9 | Group enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,711 | 8 |
ENSG00000110169 | HPX | Hemopexin | [
"P02790"
] | 11 | 6431049-6442617 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB016725",
"HPA065318",
"HPA068847"
] | [] | [
"Candidate cardiovascular disease genes",
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Host-virus interaction",
"Transport"
] | [] | [] | [] | [] | [
"Secreted to blood"
] | [
"Transport"
] | null | Approved | null | 13 | null | null | null | Cluster 15: Non-specific - Transcription | Cluster 18: Liver cancer - Metabolism | Cluster 25: Hepatocytes - Plasma protein synthesis & secretion | Cluster 53: Liver - Plasma proteins | Tissue enriched | Detected in many | 792 | Cancer enhanced | Detected in some | null | Cancer enriched | Detected in many | 69 | Cell type enriched | Detected in many | 82 | Not detected in immune cells | Not detected | null | 3 | 2 | 2 | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 3,712 | 7 |
ENSG00000110171 | TRIM3 | Tripartite motif containing 3 | [
"O75382"
] | 11 | 6448613-6474459 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043396",
"HPA048233"
] | [
"BERP",
"HAC1",
"RNF22",
"RNF97"
] | [
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [
"Transferase"
] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | Enhanced | null | 30 | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 37: Neurons - Mixed function | Cluster 27: Breast cancer - Unknown function | Cluster 65: Non-specific - Cell growth & division | Cluster 64: Non-specific - Transcription | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,713 | 3 |
ENSG00000110172 | CHORDC1 | Cysteine and histidine rich domain containing 1 | [
"Q9UHD1"
] | 11 | 90200429-90223077 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA041040"
] | [
"CHP-1",
"CHP1"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Stress response"
] | [
"Chaperone"
] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | 21 | null | null | Cluster 9: T-regs - Cell cycle regulation | Cluster 28: Oligodendrocytes - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 102: Non-specific - Mixed function | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 3,714 | 1 |
ENSG00000110195 | FOLR1 | Folate receptor alpha | [
"P15328"
] | 11 | 72189558-72196323 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"FOLR",
"FRalpha"
] | [
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Metabolic proteins",
"Predicted membrane proteins",
"Predicted secreted proteins",
"Transporters"
] | [
"Transport"
] | [
"Receptor"
] | [
"FDA approved drug targets",
"Neurodegeneration"
] | [] | [] | [
"Secreted to blood"
] | [
"Receptor"
] | null | null | null | 4 | null | null | null | Cluster 36: Choroid plexus - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 4: Breast lactating luminal cells - Lactation | Cluster 1: Choroid plexus - Transmembrane transport | Tissue enriched | Detected in many | 14 | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,715 | 9 |
ENSG00000110200 | ANAPC15 | Anaphase promoting complex subunit 15 | [
"P60006"
] | 11 | 72106378-72112780 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA036596"
] | [
"APC15",
"C11orf51",
"DKFZP564M082",
"HSPC020"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Mitosis"
] | [] | [] | [
"Nucleoplasm"
] | [
"Vesicles"
] | [] | [] | Approved | Approved | null | 20 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 34: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 106: Spermatogonia - Spermatogonial differentiation | Cluster 52: Non-specific - Cellular respiration | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,716 | 9 |
ENSG00000110203 | FOLR3 | Folate receptor gamma | [
"P41439"
] | 11 | 72114869-72139892 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"FR-G",
"FRgamma"
] | [
"Metabolic proteins",
"Predicted secreted proteins"
] | [] | [
"Receptor"
] | [] | [] | [] | [
"Secreted to blood"
] | [
"Receptor"
] | null | null | null | 1 | null | null | Cluster 21: Neutrophils - Unknown function | null | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 15: Bone marrow - Innate immune response | Group enriched | Detected in some | 10 | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in many | 11 | 0 | 0 | 0 | [] | [] | [] | 3,717 | 9 |
ENSG00000110237 | ARHGEF17 | Rho guanine nucleotide exchange factor 17 | [
"Q96PE2"
] | 11 | 73308276-73369388 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA007991",
"HPA074658"
] | [
"KIAA0337",
"p164-RhoGEF",
"TEM4"
] | [
"Predicted intracellular proteins"
] | [] | [
"Guanine-nucleotide releasing factor"
] | [] | [
"Cytosol"
] | [
"Plasma membrane"
] | [] | [] | Approved | Uncertain | null | 10 | null | null | null | Cluster 32: Cerebral cortex - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 110: Mural cells - ECM organization | Cluster 74: Non-specific - Signal transduction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 3,719 | 7 |
ENSG00000110243 | APOA5 | Apolipoprotein A5 | [
"Q6Q788"
] | 11 | 116789367-116792420 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"APOA-V",
"RAP3"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Lipid transport",
"Transport"
] | [] | [
"Disease variant"
] | [] | [] | [
"Secreted to blood"
] | [
"Apolipoprotein"
] | null | null | null | 12 | null | null | null | null | Cluster 18: Liver cancer - Metabolism | Cluster 93: Hepatocytes - Bile production & excretion | Cluster 31: Liver - Metabolism & Coagulation | Tissue enriched | Detected in some | 227 | Cancer enriched | Detected in single | 18 | Cancer enriched | Detected in single | 309 | Cell type enriched | Detected in some | 387 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Liver Hepatocellular Carcinoma"
] | [] | [
"Liver Hepatocellular Carcinoma"
] | 3,720 | 5 |
ENSG00000110244 | APOA4 | Apolipoprotein A4 | [
"P06727"
] | 11 | 116820700-116823304 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001352",
"HPA002549",
"CAB068250",
"CAB068251",
"CAB068252"
] | [] | [
"Candidate cardiovascular disease genes",
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Lipid transport",
"Transport"
] | [] | [
"Amyloidosis",
"Disease variant"
] | [
"Vesicles"
] | [] | [
"Secreted to blood"
] | [
"Apolipoprotein"
] | Approved | Enhanced | null | 7 | null | null | null | null | Cluster 34: Testis cancer - Unknown function | Cluster 1: Enterocytes - Absorption and Digestion | Cluster 7: Small intestine - Absorption and Digestion | Tissue enriched | Detected in some | 12 | Cancer enriched | Detected in single | 7 | Cancer enriched | Detected in some | 24 | Cell type enriched | Detected in some | 65 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,721 | 3 |
ENSG00000110245 | APOC3 | Apolipoprotein C3 | [
"P02656"
] | 11 | 116829706-116833072 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA065365",
"HPA073918"
] | [
"Apo-C3",
"Apo-CIII",
"ApoC-3",
"ApoC-III",
"APOCIII"
] | [
"Cancer-related genes",
"Candidate cardiovascular disease genes",
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Lipid degradation",
"Lipid metabolism",
"Lipid transport",
"Transport"
] | [] | [
"Cancer-related genes",
"Disease variant",
"FDA approved drug targets"
] | [
"Nucleoplasm"
] | [
"Nucleoli",
"Cell Junctions"
] | [
"Secreted to blood"
] | [
"Apolipoprotein"
] | Approved | Supported | null | 8 | null | null | null | null | Cluster 18: Liver cancer - Metabolism | Cluster 93: Hepatocytes - Bile production & excretion | Cluster 53: Liver - Plasma proteins | Tissue enriched | Detected in many | 25 | Cancer enriched | Detected in some | 4 | Cancer enriched | Detected in many | 453 | Cell type enriched | Detected in some | 9 | Not detected in immune cells | Not detected | null | 1 | 2 | 0 | [
"Liver Hepatocellular Carcinoma"
] | [] | [
"Liver Hepatocellular Carcinoma"
] | 3,722 | 4 |
ENSG00000110274 | CEP164 | Centrosomal protein 164 | [
"Q9UPV0"
] | 11 | 117314557-117413266 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA037605",
"HPA037606",
"HPA061504"
] | [
"KIAA1052",
"NPHP15"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Cilium biogenesis/degradation",
"DNA damage",
"DNA repair",
"Mitosis"
] | [] | [
"Ciliopathy",
"Disease variant",
"Nephronophthisis"
] | [
"Primary cilium transition zone",
"Centrosome",
"Principal piece"
] | [
"Nucleoplasm",
"Vesicles",
"Equatorial segment"
] | [] | [] | Approved | Uncertain | null | 17 | null | null | Cluster 32: Basophils - Transcription | Cluster 6: Non-specific - Immune response | Cluster 24: Non-specific - Unknown function | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 8: Pancreas - Proteolysis | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 3,723 | 4 |
ENSG00000110318 | CEP126 | Centrosomal protein 126 | [
"Q9P2H0"
] | 11 | 101915010-102001062 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"KIAA1377"
] | [
"Predicted intracellular proteins"
] | [
"Cilium biogenesis/degradation"
] | [] | [] | [] | [] | [] | [] | null | null | null | 17 | null | null | null | Cluster 17: Choroid plexus - Cilium | Cluster 11: Neuronal - Sensory perception | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 48: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in single | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,725 | 2 |
ENSG00000110321 | EIF4G2 | Eukaryotic translation initiation factor 4 gamma 2 | [
"P78344"
] | 11 | 10797050-10808940 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB005163",
"HPA006773",
"HPA016965"
] | [
"DAP5",
"NAT1",
"p97"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Protein biosynthesis",
"Translation regulation"
] | [
"Initiation factor",
"Repressor"
] | [] | [
"Cytosol"
] | [] | [] | [] | Enhanced | Approved | null | 27 | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 44: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 39: Syncytiotrophoblasts - Placental homeostasis & endocrine signal | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 3,726 | 5 |
ENSG00000110324 | IL10RA | Interleukin 10 receptor subunit alpha | [
"Q13651"
] | 11 | 117986370-118003037 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA065647",
"HPA069086"
] | [
"CD210",
"CD210a",
"CDW210A",
"HIL-10R",
"IL10R"
] | [
"CD markers",
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [] | [
"Receptor"
] | [
"Disease variant"
] | [
"Plasma membrane",
"Cytosol"
] | [
"Primary cilium"
] | [] | [] | Supported | null | null | 30 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 22: Non-specific - Mixed function | Cluster 55: Lymphoma - Immune response | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 3,727 | 2 |
ENSG00000110328 | GALNT18 | Polypeptide N-acetylgalactosaminyltransferase 18 | [
"Q6P9A2"
] | 11 | 11270877-11622005 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA012955",
"HPA070681"
] | [
"GalNAc-T18",
"GALNT15",
"GALNTL4",
"MGC71806"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted membrane proteins"
] | [] | [
"Glycosyltransferase",
"Transferase"
] | [] | [
"Golgi apparatus"
] | [
"Vesicles",
"Cytosol"
] | [] | [] | Approved | Approved | null | 27 | null | null | null | Cluster 29: Forebrain - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,728 | 5 |
ENSG00000110330 | BIRC2 | Baculoviral IAP repeat containing 2 | [
"Q13490"
] | 11 | 102347211-102378670 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA005513",
"CAB020661"
] | [
"API1",
"c-IAP1",
"cIAP1",
"hiap-2",
"MIHB",
"RNF48"
] | [
"Cancer-related genes",
"Enzymes",
"Predicted intracellular proteins"
] | [
"Apoptosis",
"Transcription",
"Transcription regulation",
"Ubl conjugation pathway"
] | [
"Activator",
"Transferase"
] | [
"Cancer-related genes"
] | [
"Nucleoli fibrillar center",
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Supported | null | 131 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 55: Non-specific - Transcription | Cluster 72: Neuronal - Signal transduction | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 51: Lymphoid tissue - Adaptive immune response | Low tissue specificity | Detected in all | null | Cancer enriched | Detected in all | 4 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 3,729 | 8 |
ENSG00000110367 | DDX6 | DEAD-box helicase 6 | [
"P26196"
] | 11 | 118747763-118791164 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB004668",
"HPA024201",
"HPA026644"
] | [
"HLR2",
"RCK",
"Rck/p54"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Helicase",
"Hydrolase",
"RNA-binding"
] | [
"Cancer-related genes",
"Disease variant",
"Intellectual disability",
"Proto-oncogene"
] | [
"Cytoplasmic bodies"
] | [
"Plasma membrane",
"Midbody",
"Cytosol"
] | [] | [] | Supported | Approved | null | 307 | Yes | null | Cluster 21: Neutrophils - Unknown function | Cluster 31: Non-specific - Transcription | Cluster 24: Non-specific - Unknown function | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 3,731 | 1 |
ENSG00000110375 | UPK2 | Uroplakin 2 | [
"O00526"
] | 11 | 118925164-118958559 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043312",
"HPA061106"
] | [
"MGC138598",
"UP2",
"UPII"
] | [
"Predicted membrane proteins",
"Transporters"
] | [] | [] | [] | [] | [] | [] | [] | null | Enhanced | null | 71 | null | null | null | null | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 69: Urothelial cells - Basic cellular functions | Cluster 11: Esophagus - Basic cellular processes | Tissue enriched | Detected in some | 25 | Cancer enhanced | Detected in many | null | Cancer enriched | Detected in many | 63 | Cell type enriched | Detected in many | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,732 | 6 |
ENSG00000110395 | CBL | Cbl proto-oncogene | [
"P22681"
] | 11 | 119206298-119313926 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB004350",
"HPA027956"
] | [
"c-Cbl",
"CBL2",
"RNF55"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Ubl conjugation pathway"
] | [
"Transferase"
] | [
"Cancer-related genes",
"Disease variant",
"Proto-oncogene"
] | [
"Cytosol"
] | [
"Mitotic spindle",
"End piece"
] | [] | [] | Supported | Enhanced | null | 201 | Yes | null | Cluster 7: Non-specific - Innate immune response | Cluster 19: Astrocytes - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 51: Lymphoid tissue - Adaptive immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 3,733 | 6 |
ENSG00000110400 | NECTIN1 | Nectin cell adhesion molecule 1 | [
"Q15223"
] | 11 | 119623408-119729200 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB016135",
"HPA026846"
] | [
"CD111",
"CLPED1",
"ED4",
"HIgR",
"HVEC",
"Nectin-1",
"OFC7",
"PRR",
"PRR1",
"PVRL1",
"PVRR1",
"SK-12"
] | [
"CD markers",
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [
"Cell adhesion",
"Host-virus interaction"
] | [
"Host cell receptor for virus entry",
"Receptor"
] | [
"Disease variant",
"Ectodermal dysplasia"
] | [] | [] | [
"Secreted in other tissues"
] | [
"Receptor"
] | null | Approved | null | 10 | null | null | Cluster 8: Plasmacytoid DCs - Unknown function | Cluster 11: White matter - Signal transduction | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 81: Squamous epithelium - Keratinization | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,734 | 2 |
ENSG00000110422 | HIPK3 | Homeodomain interacting protein kinase 3 | [
"Q9H422"
] | 11 | 33256672-33357023 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA028069"
] | [
"DYRK6",
"FIST3",
"PKY",
"YAK1"
] | [
"Enzymes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Apoptosis",
"Transcription",
"Transcription regulation"
] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [] | [
"Cytosol"
] | [
"Nuclear bodies"
] | [] | [] | Supported | Approved | null | 1 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 39: Astrocytes - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Uterine Corpus Endometrial Carcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 3,735 | 2 |
ENSG00000110427 | KIAA1549L | KIAA1549 like | [
"Q6ZVL6"
] | 11 | 33376108-33674102 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA010132",
"HPA051594"
] | [
"C11orf41",
"C11orf69",
"G2",
"MGC34830"
] | [
"Predicted membrane proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Vesicles"
] | [] | [] | Approved | null | null | null | null | null | null | Cluster 53: Neurons - Mixed function | Cluster 72: Neuronal - Signal transduction | Cluster 19: Cerebellar purkinje cells - Neurotransmission & signaling | Cluster 73: Brain - Neuronal signaling | Group enriched | Detected in some | 14 | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 3,736 | 1 |
ENSG00000110429 | FBXO3 | F-box protein 3 | [
"Q9UK99"
] | 11 | 33740939-33774543 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA002467"
] | [
"FBA",
"FBX3"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Host-virus interaction",
"Ubl conjugation pathway"
] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | null | null | 17 | null | null | Cluster 39: T-cells - T-cell receptor | Cluster 31: Non-specific - Transcription | Cluster 24: Non-specific - Unknown function | Cluster 42: Early spermatids - Spermiogenesis: Acrosomal phase | Cluster 30: Skeletal muscle - Striated muscle contraction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 3,737 | 3 |
ENSG00000110435 | PDHX | Pyruvate dehydrogenase complex component X | [
"O00330"
] | 11 | 34915829-35020591 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038484",
"HPA038485"
] | [
"DLDBP",
"E3BP",
"OPDX",
"PDX1",
"proX"
] | [
"Disease related genes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Mitochondria"
] | [
"Plasma membrane"
] | [] | [] | Approved | Enhanced | null | 17 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 34: Non-specific - Mixed function | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 89: Adipocytes - Lipid metabolism | Cluster 62: Skeletal muscle - Muscle contraction | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,738 | 1 |
ENSG00000110436 | SLC1A2 | Solute carrier family 1 member 2 | [
"P43004"
] | 11 | 35251205-35420063 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB002574",
"HPA009172",
"HPA067499"
] | [
"EAAT2",
"GLT-1",
"GLT1",
"HBGT"
] | [
"Disease related genes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Amino-acid transport",
"Symport",
"Transport"
] | [] | [
"Disease variant",
"Epilepsy"
] | [] | [] | [] | [] | null | Enhanced | null | 3 | null | null | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 28: Astrocytes - Homeostasis & neuron support | Cluster 78: Brain - Neuronal signaling | Tissue enriched | Detected in many | 18 | Cancer enhanced | Detected in some | null | Cancer enriched | Detected in some | 7 | Cell type enriched | Detected in many | 6 | Immune cell enhanced | Detected in single | null | 0 | 0 | 0 | [] | [] | [] | 3,739 | 9 |
ENSG00000110442 | COMMD9 | COMM domain containing 9 | [
"Q9P000"
] | 11 | 36269284-36289449 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA009142"
] | [
"FLJ31106",
"HSPC166"
] | [
"Predicted intracellular proteins"
] | [
"Ion transport",
"Sodium transport",
"Transcription",
"Transcription regulation",
"Transport",
"Ubl conjugation pathway"
] | [] | [] | [
"Nucleoplasm"
] | [
"Golgi apparatus",
"Cytosol"
] | [] | [] | Supported | Uncertain | null | 42 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 27: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,740 | 8 |
ENSG00000110446 | SLC15A3 | Solute carrier family 15 member 3 | [
"Q8IY34"
] | 11 | 60937060-60952653 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA047880",
"HPA057642"
] | [
"hPTR3",
"PHT2"
] | [
"Metabolic proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Immunity",
"Innate immunity",
"Peptide transport",
"Protein transport",
"Symport",
"Transport"
] | [] | [] | [
"Vesicles"
] | [] | [] | [] | Supported | Approved | null | 41 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 20: Macrophages & Microglia - Immune response | Cluster 55: Lymphoma - Immune response | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 5 | 0 | 0 | 0 | [] | [] | [] | 3,741 | 9 |
ENSG00000110448 | CD5 | CD5 molecule | [
"P06127"
] | 11 | 61102489-61127852 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB015392",
"CAB020308",
"HPA043416",
"HPA060839"
] | [
"LEU1",
"T1"
] | [
"CD markers",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | Enhanced | null | 1 | null | null | Cluster 6: T-cells - T-cell receptor | Cluster 32: Cerebral cortex - Mixed function | Cluster 59: Leukemia - T-cell receptor | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 51: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in some | 7 | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in many | null | 2 | 0 | 2 | [
"Head and Neck Squamous Cell Carcinoma",
"Lung Adenocarcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Lung Adenocarcinoma"
] | 3,742 | 2 |
ENSG00000110455 | ACCS | 1-aminocyclopropane-1-carboxylate synthase homolog (inactive) | [
"Q96QU6"
] | 11 | 44065925-44084237 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA018873",
"HPA021654"
] | [
"ACS",
"PHACS"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Golgi apparatus"
] | [] | [] | [] | Approved | Approved | null | 1 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 36: Choroid plexus - Mixed function | Cluster 5: Rhabdoid - Unknown function | Cluster 7: Non-specific - Transcription | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Papillary Cell Carcinoma",
"Lung Adenocarcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Papillary Cell Carcinoma",
"Lung Adenocarcinoma"
] | 3,743 | 2 |
ENSG00000110484 | SCGB2A2 | Secretoglobin family 2A member 2 | [
"Q13296"
] | 11 | 62270158-62273160 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB026270"
] | [
"MGB1",
"MGC71974",
"PSBP1",
"UGB2"
] | [
"Cancer-related genes",
"Predicted secreted proteins"
] | [] | [] | [
"Cancer-related genes"
] | [] | [] | [
"Secreted in female reproductive system"
] | [
"No annotated function"
] | null | Enhanced | null | 1 | null | null | null | null | Cluster 27: Breast cancer - Unknown function | Cluster 38: Secretory epithelial cells - Exocrine secretion | Cluster 55: Breast - Lactation | Group enriched | Detected in some | 6 | Cancer enriched | Detected in some | 161 | Cancer enriched | Detected in many | 65 | Group enriched | Detected in some | 7 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,744 | 8 |
ENSG00000110492 | MDK | Midkine | [
"P21741"
] | 11 | 46380756-46383837 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB010055",
"HPA057126"
] | [
"FLJ27379",
"MK",
"NEGF2"
] | [
"Cancer-related genes",
"Predicted secreted proteins"
] | [
"Differentiation"
] | [
"Developmental protein",
"Growth factor",
"Heparin-binding",
"Mitogen"
] | [
"Cancer-related genes"
] | [
"Vesicles"
] | [] | [
"Secreted to blood"
] | [
"Growth factor"
] | Approved | Uncertain | null | 15 | null | null | null | Cluster 56: Hypothalamus - Neuropeptide signaling | Cluster 2: Mucus-secreting cells - Unknown function | Cluster 94: Gonadal somatic cells - Mixed function | Cluster 75: Ovary - Mixed function | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 2 | 2 | 1 | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 3,745 | 8 |
ENSG00000110514 | MADD | MAP kinase activating death domain | [
"Q8WXG6"
] | 11 | 47269161-47330031 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038568"
] | [
"DENN",
"KIAA0358",
"RAB3GEP"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Apoptosis"
] | [
"Guanine-nucleotide releasing factor"
] | [
"Intellectual disability"
] | [
"Plasma membrane",
"Cytosol"
] | [] | [] | [] | Supported | Uncertain | null | 8 | null | null | Cluster 32: Basophils - Transcription | Cluster 34: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling | Cluster 27: Cerebellum - Synaptic function | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 2 | 0 | 2 | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Pancreatic Adenocarcinoma"
] | 3,747 | 9 |
ENSG00000110536 | PTPMT1 | Protein tyrosine phosphatase mitochondrial 1 | [
"Q8WUK0"
] | 11 | 47565430-47573461 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043932",
"HPA060060"
] | [
"DUSP23",
"MOSP",
"PLIP"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Lipid biosynthesis",
"Lipid metabolism",
"Phospholipid biosynthesis",
"Phospholipid metabolism"
] | [
"Hydrolase",
"Protein phosphatase"
] | [] | [
"Mitochondria"
] | [] | [] | [] | Enhanced | Approved | null | 31 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 21: Non-specific - Metabolism | Cluster 24: Non-specific - Unknown function | Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 2 | 0 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 3,748 | 3 |
ENSG00000110583 | NAA40 | N-alpha-acetyltransferase 40, NatD catalytic subunit | [
"Q86UY6"
] | 11 | 63938959-63957319 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA037816",
"HPA056142"
] | [
"FLJ13848",
"NAT11"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Acyltransferase",
"Transferase"
] | [] | [
"Nucleoplasm"
] | [
"Centriolar satellite",
"Cytosol"
] | [] | [] | Supported | Uncertain | null | 31 | null | null | Cluster 41: Basophils - Unknown function | Cluster 17: Choroid plexus - Cilium | Cluster 24: Non-specific - Unknown function | Cluster 56: Late spermatids - Spermiogenesis: Maturation | Cluster 56: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 3,749 | 7 |
ENSG00000110651 | CD81 | CD81 molecule | [
"P60033"
] | 11 | 2376177-2397802 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB002507",
"HPA007234"
] | [
"TAPA-1",
"TAPA1",
"TSPAN28"
] | [
"CD markers",
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Adaptive immunity",
"Host-virus interaction",
"Immunity"
] | [
"Host cell receptor for virus entry",
"Receptor"
] | [] | [
"Plasma membrane"
] | [
"Cytosol"
] | [] | [] | Approved | Supported | null | 50 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 19: Astrocytes - Mixed function | Cluster 44: Connective tissue cells - ECM organization | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 74: Non-specific - Signal transduction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Group enriched | Detected in many | 4 | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 3,752 | 8 |
ENSG00000110660 | SLC35F2 | Solute carrier family 35 member F2 | [
"Q8IXU6"
] | 11 | 107790991-107928293 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA048185",
"HPA060150"
] | [
"FLJ13018"
] | [
"Predicted membrane proteins",
"Transporters"
] | [
"Transport"
] | [] | [] | [
"Golgi apparatus"
] | [] | [] | [] | Approved | Enhanced | null | 20 | null | null | Cluster 16: Non-specific - Cell proliferation | Cluster 39: Astrocytes - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 26: Keratinocytes - Keratinization | Cluster 38: Non-specific - Basic cellular processes | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 6 | 0 | 6 | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Chromophobe",
"Lung Adenocarcinoma",
"Lung Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma",
"Skin Cutaneous Melanoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Chromophobe",
"Lung Adenocarcinoma",
"Lung Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma",
"Skin Cutaneous Melanoma"
] | 3,753 | 4 |
ENSG00000110665 | C11orf21 | Chromosome 11 open reading frame 21 | [
"Q9P2W6"
] | 11 | 2295628-2303049 | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | [
"HPA037607"
] | [] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Approved | null | null | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 20: Macrophages & Microglia - Immune response | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Group enriched | Detected in many | 6 | Cancer enriched | Detected in some | 9 | Low cancer specificity | Detected in some | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 3,754 | 6 |
ENSG00000110680 | CALCA | Calcitonin related polypeptide alpha | [
"P01258",
"P06881"
] | 11 | 14966622-14972354 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA059886",
"HPA064453"
] | [
"CALC1",
"CGRP",
"CGRP-alpha"
] | [
"Cancer-related genes",
"FDA approved drug targets",
"Plasma proteins",
"Predicted secreted proteins",
"Transporters"
] | [] | [
"Hormone"
] | [
"Cancer-related genes",
"FDA approved drug targets"
] | [] | [] | [
"Secreted to blood"
] | [
"Hormone"
] | null | Enhanced | Supported | 7 | null | null | null | Cluster 43: Hindbrain - Mixed function | Cluster 16: Thyroid cancer - Neuronal signaling | Cluster 103: Non-specific - Basic cellular processes | Cluster 69: Parathyroid gland - Mixed function | Group enriched | Detected in some | 4 | Cancer enriched | Detected in many | 13 | Cancer enriched | Detected in many | 4 | Group enriched | Detected in some | 5 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 3,756 | 1 |
ENSG00000110693 | SOX6 | SRY-box transcription factor 6 | [
"P35712"
] | 11 | 15966449-16739591 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001923",
"HPA003908"
] | [] | [
"Disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Differentiation",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Developmental protein",
"DNA-binding",
"Repressor"
] | [
"Autism spectrum disorder",
"Disease variant",
"Intellectual disability"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Enhanced | null | 20 | null | null | null | Cluster 39: Astrocytes - Mixed function | Cluster 47: Leukemia - Hemostasis | Cluster 14: Oligodendrocyte progenitor cells - Development & myelination | Cluster 44: Bone marrow - Nuclear processes | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in single | 20 | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 3,757 | 5 |
ENSG00000110696 | C11orf58 | Chromosome 11 open reading frame 58 | [
"O00193"
] | 11 | 16613132-16758340 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA036591",
"HPA076406"
] | [
"SMAP"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Endoplasmic reticulum"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Uncertain | null | 1 | null | null | Cluster 41: Basophils - Unknown function | Cluster 55: Non-specific - Transcription | Cluster 24: Non-specific - Unknown function | Cluster 39: Syncytiotrophoblasts - Placental homeostasis & endocrine signal | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 3,758 | 5 |
ENSG00000110697 | PITPNM1 | Phosphatidylinositol transfer protein membrane associated 1 | [
"O00562"
] | 11 | 67491768-67506263 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA060227"
] | [
"DRES9",
"NIR2",
"PITPNM",
"Rd9",
"RDGB",
"RDGB1",
"RDGBA1"
] | [
"Predicted intracellular proteins",
"Transporters"
] | [
"Protein transport",
"Transport"
] | [] | [] | [
"Cytosol"
] | [
"Vesicles"
] | [] | [] | Supported | Approved | null | 9 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 38: Sub-cortical - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 107: Ciliated cells - Cilia assembly & function | Cluster 46: Brain & retina - Neuronal signaling | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,759 | 1 |
ENSG00000110700 | RPS13 | Ribosomal protein S13 | [
"P62277"
] | 11 | 17074388-17077715 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA005985"
] | [
"S13"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins",
"Ribosomal proteins"
] | [] | [
"Ribonucleoprotein",
"Ribosomal protein"
] | [] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Approved | Uncertain | null | 198 | null | null | Cluster 18: Non-specific - Translation | Cluster 7: Non-specific - Ribosome | Cluster 25: Non-specific - Ribosome | Cluster 15: Non-specific - Protein processing | Cluster 54: Non-specific - Ribosome | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [
"Rectum Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma"
] | 3,760 | 9 |
ENSG00000110711 | AIP | Aryl hydrocarbon receptor interacting protein | [
"O00170"
] | 11 | 67468174-67491154 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB033674",
"HPA050217",
"CAB069477"
] | [
"ARA9",
"FKBP16",
"FKBP37",
"XAP2"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [
"Cushing syndrome"
] | [
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 46 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 28: Oligodendrocytes - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 97: Non-specific - Cellular respiration | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe"
] | 3,761 | 7 |
ENSG00000110717 | NDUFS8 | NADH:ubiquinone oxidoreductase core subunit S8 | [
"O00217"
] | 11 | 68030617-68036644 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA018524",
"HPA067429"
] | [
"CI-23k",
"TYKY"
] | [
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Electron transport",
"Respiratory chain",
"Transport"
] | [
"Oxidoreductase",
"Translocase"
] | [
"Disease variant",
"Primary mitochondrial disease"
] | [
"Mitochondria"
] | [] | [] | [] | Approved | Enhanced | null | 63 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 21: Non-specific - Metabolism | Cluster 24: Non-specific - Unknown function | Cluster 97: Non-specific - Cellular respiration | Cluster 52: Non-specific - Cellular respiration | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Bladder Urothelial Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 3,763 | 6 |
ENSG00000110719 | TCIRG1 | T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 | [
"Q13488"
] | 11 | 68039025-68050895 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA038742"
] | [
"a3",
"Atp6i",
"ATP6N1C",
"ATP6V0A3",
"OC-116",
"OC116",
"TIRC7"
] | [
"Disease related genes",
"Human disease related genes",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Hydrogen ion transport",
"Ion transport",
"Transport"
] | [] | [
"Disease variant",
"Osteopetrosis"
] | [
"Mitochondria"
] | [] | [] | [] | Approved | Approved | null | 27 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 12: Non-specific - Vasculature | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 70: Non-specific - Protein processing | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,764 | 3 |
ENSG00000110721 | CHKA | Choline kinase alpha | [
"P35790"
] | 11 | 68052859-68121444 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA024153",
"CAB072803"
] | [
"CHK",
"CKI"
] | [
"Enzymes",
"Essential proteins",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Lipid biosynthesis",
"Lipid metabolism",
"Phospholipid biosynthesis",
"Phospholipid metabolism"
] | [
"Kinase",
"Transferase",
"Tyrosine-protein kinase"
] | [
"Disease variant",
"Epilepsy",
"Intellectual disability"
] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Approved | Approved | null | 2 | null | Yes | Cluster 45: Eosinophils - Unknown function | Cluster 28: Oligodendrocytes - Mixed function | Cluster 18: Liver cancer - Metabolism | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 21: Testis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Immune cell enhanced | Detected in some | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 3,765 | 7 |
ENSG00000110756 | HPS5 | HPS5 biogenesis of lysosomal organelles complex 2 subunit 2 | [
"Q9UPZ3"
] | 11 | 18278668-18322198 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA077851"
] | [
"AIBP63",
"BLOC2S2",
"RU2"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [
"Albinism",
"Disease variant",
"Hermansky-Pudlak syndrome"
] | [
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | null | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 55: Non-specific - Transcription | Cluster 69: Skin cancer - ECM organization | Cluster 102: Non-specific - Mixed function | Cluster 31: Liver - Metabolism & Coagulation | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe"
] | 3,767 | 8 |
ENSG00000110768 | GTF2H1 | General transcription factor IIH subunit 1 | [
"P32780"
] | 11 | 18322295-18367045 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB004637",
"HPA046660"
] | [
"BTF2",
"P62",
"TFIIH"
] | [
"Cancer-related genes",
"Essential proteins",
"Predicted intracellular proteins"
] | [
"DNA damage",
"DNA repair",
"Host-virus interaction",
"Transcription",
"Transcription regulation"
] | [] | [
"Cancer-related genes"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Enhanced | null | 69 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 31: Non-specific - Transcription | Cluster 24: Non-specific - Unknown function | Cluster 102: Non-specific - Mixed function | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 3,768 | 1 |
ENSG00000110777 | POU2AF1 | POU class 2 homeobox associating factor 1 | [
"Q16633"
] | 11 | 111352255-111455630 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB011193"
] | [
"BOB1",
"OBF1",
"OCA-B"
] | [
"Cancer-related genes",
"Disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator"
] | [
"Cancer-related genes",
"Proto-oncogene"
] | [] | [] | [] | [] | null | Enhanced | null | 39 | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 8: Immune cells - Immune response | Cluster 46: Lymphoma - Humoral immune response | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 18: Lymphoid tissue - Immune response | Group enriched | Detected in many | 4 | Group enriched | Detected in many | 7 | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in some | 7 | 2 | 0 | 2 | [
"Breast Invasive Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 3,769 | 3 |
ENSG00000110786 | PTPN5 | Protein tyrosine phosphatase non-receptor type 5 | [
"P54829"
] | 11 | 18727928-18792721 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA031014",
"HPA072091"
] | [
"PTPSTEP",
"STEP",
"STEP61"
] | [
"Enzymes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Hydrolase",
"Protein phosphatase"
] | [] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Approved | Supported | null | 23 | null | null | null | Cluster 33: Neurons - Mixed function | Cluster 3: Rhabdoid - Membrane components | Cluster 35: Neurons - Synaptic function & neurogenesis | Cluster 78: Brain - Neuronal signaling | Tissue enriched | Detected in many | 25 | Group enriched | Detected in some | 4 | Group enriched | Detected in some | 7 | Group enriched | Detected in some | 5 | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Rectum Adenocarcinoma"
] | [] | [
"Rectum Adenocarcinoma"
] | 3,770 | 6 |
ENSG00000110799 | VWF | Von Willebrand factor | [
"P04275"
] | 12 | 5948877-6124770 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB001694",
"HPA001815",
"HPA002082",
"CAB072874",
"CAB072875"
] | [
"F8VWF"
] | [
"Cancer-related genes",
"Candidate cardiovascular disease genes",
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Plasma proteins",
"Predicted secreted proteins"
] | [
"Blood coagulation",
"Cell adhesion",
"Hemostasis"
] | [] | [
"Cancer-related genes",
"Disease variant",
"FDA approved drug targets",
"von Willebrand disease"
] | [] | [] | [
"Secreted to blood"
] | [
"Blood coagulation"
] | null | Supported | null | 12 | null | null | null | Cluster 47: Endothelial cells - Vasculature | Cluster 48: Adipocytes & Endothelial cells - Angiogenesis | Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in some | null | Cancer enriched | Detected in all | 4 | Group enriched | Detected in many | 4 | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Stomach Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Stomach Adenocarcinoma"
] | 3,771 | 8 |
ENSG00000110801 | PSMD9 | Proteasome 26S subunit, non-ATPase 9 | [
"O00233"
] | 12 | 121888732-121918297 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA040512",
"HPA044220"
] | [
"p27",
"Rpn4"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Chaperone"
] | [] | [
"Cytosol"
] | [
"Plasma membrane"
] | [] | [] | Supported | Enhanced | null | 63 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 21: Non-specific - Metabolism | Cluster 38: Non-specific - Transcription | Cluster 97: Non-specific - Cellular respiration | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 3,772 | 7 |
ENSG00000110811 | P3H3 | Prolyl 3-hydroxylase 3 | [
"Q8IVL6"
] | 12 | 6828407-6839847 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043695"
] | [
"GRCB",
"HSU47926",
"LEPREL2"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [] | [
"Dioxygenase",
"Oxidoreductase"
] | [] | [
"Plasma membrane",
"Cytosol"
] | [
"Nucleoli"
] | [
"Intracellular and membrane"
] | [
"Enzyme"
] | Approved | Approved | null | 27 | null | null | null | Cluster 48: Non-specific - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 94: Gonadal somatic cells - Mixed function | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Pancreatic Adenocarcinoma"
] | [] | [
"Pancreatic Adenocarcinoma"
] | 3,773 | 7 |
ENSG00000110841 | PPFIBP1 | PPFIA binding protein 1 | [
"Q86W92"
] | 12 | 27523431-27695564 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001924",
"HPA071162"
] | [
"hSGT2",
"hSgt2p",
"L2",
"SGT2"
] | [
"Cancer-related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [
"Cancer-related genes",
"Disease variant",
"Epilepsy",
"Intellectual disability"
] | [
"Plasma membrane"
] | [] | [] | [] | Enhanced | Uncertain | null | 47 | null | null | Cluster 18: Non-specific - Translation | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 15: Kidney cancer - Membrane components | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 35: Non-specific - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 3,774 | 8 |
ENSG00000110844 | PRPF40B | Pre-mRNA processing factor 40 homolog B | [
"Q6NWY9"
] | 12 | 49568218-49644666 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038426",
"HPA038599"
] | [
"HYPC"
] | [
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing"
] | [] | [] | [
"Nuclear bodies"
] | [
"Nucleoplasm",
"Aggresome",
"Cytosol"
] | [] | [] | Approved | Enhanced | null | 6 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 32: Cerebral cortex - Mixed function | Cluster 51: Myeloma - Immunoglobulins | Cluster 46: Skeletal myocytes - Muscle structure & formation | Cluster 21: Testis - Mixed function | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in some | null | 2 | 0 | 2 | [
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,775 | 4 |
ENSG00000110848 | CD69 | CD69 molecule | [
"Q07108"
] | 12 | 9752486-9760901 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB002503",
"HPA050525"
] | [
"CLEC2C"
] | [
"CD markers",
"Predicted membrane proteins"
] | [] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | Enhanced | null | 13 | null | null | Cluster 24: Non-specific - Transcription | Cluster 8: Immune cells - Immune response | Cluster 46: Lymphoma - Humoral immune response | Cluster 58: Mast cells - Allergic inflammatory responses | Cluster 15: Bone marrow - Innate immune response | Group enriched | Detected in many | 5 | Group enriched | Detected in some | 6 | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 5 | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Breast Invasive Carcinoma",
"Rectum Adenocarcinoma"
] | [] | [
"Breast Invasive Carcinoma",
"Rectum Adenocarcinoma"
] | 3,776 | 4 |
ENSG00000110851 | PRDM4 | PR/SET domain 4 | [
"Q9UKN5"
] | 12 | 107732871-107761272 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA024322",
"HPA067437"
] | [
"PFM1"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding",
"Methyltransferase",
"Transferase"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 3 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 38: Non-specific - Transcription | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 69: Parathyroid gland - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 3,777 | 8 |
ENSG00000110852 | CLEC2B | C-type lectin domain family 2 member B | [
"Q92478"
] | 12 | 9852369-9869386 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA008194"
] | [
"AICL",
"CLECSF2",
"HP10085"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [
"Intracellular and membrane"
] | [
"No annotated function"
] | null | Enhanced | null | 82 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 12: Non-specific - Vasculature | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 15: Bone marrow - Innate immune response | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in all | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 3,778 | 7 |
ENSG00000110871 | COQ5 | Coenzyme Q5, methyltransferase | [
"Q5HYK3"
] | 12 | 120503279-120534434 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA049487"
] | [
"MGC4767"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Ubiquinone biosynthesis"
] | [
"Methyltransferase",
"Transferase"
] | [
"Primary mitochondrial disease"
] | [
"Nucleoli",
"Mitochondria"
] | [] | [] | [] | Approved | Approved | null | 25 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 11: White matter - Signal transduction | Cluster 38: Non-specific - Transcription | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 19: Skeletal muscle - Striated muscle contraction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 3,779 | 9 |
ENSG00000110876 | SELPLG | Selectin P ligand | [
"Q14242"
] | 12 | 108621895-108633894 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB002431",
"HPA011256",
"HPA069062"
] | [
"CD162",
"PSGL-1"
] | [
"Candidate cardiovascular disease genes",
"CD markers",
"Plasma proteins",
"Predicted membrane proteins"
] | [
"Cell adhesion",
"Host-virus interaction"
] | [
"Host cell receptor for virus entry",
"Receptor"
] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | Enhanced | null | 3 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 20: Macrophages & Microglia - Immune response | Cluster 51: Myeloma - Immunoglobulins | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Head and Neck Squamous Cell Carcinoma"
] | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | 3,780 | 2 |
ENSG00000110880 | CORO1C | Coronin 1C | [
"Q9ULV4"
] | 12 | 108645109-108731526 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA041737"
] | [
"coronin-3",
"HCRNN4"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Actin-binding"
] | [] | [] | [] | [] | [] | null | Approved | null | 53 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 13: Oligodendrocytes - Mixed function | Cluster 72: Neuronal - Signal transduction | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 12: Smooth muscle tissue - ECM organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 3,781 | 2 |
ENSG00000110881 | ASIC1 | Acid sensing ion channel subunit 1 | [
"P78348"
] | 12 | 50057548-50083611 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA058870"
] | [
"ACCN2",
"BNaC2",
"hBNaC2"
] | [
"Predicted membrane proteins"
] | [
"Calcium transport",
"Ion transport",
"Sodium transport",
"Transport"
] | [
"Ion channel",
"Sodium channel"
] | [] | [
"Golgi apparatus",
"Plasma membrane"
] | [] | [] | [] | Supported | null | null | 5 | null | null | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 71: Lymphoma - Inflammatory response | Cluster 14: Oligodendrocyte progenitor cells - Development & myelination | Cluster 10: Brain - Synaptic signal transduction | Tissue enriched | Detected in many | 6 | Low cancer specificity | Detected in many | null | Cancer enriched | Detected in many | 5 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Head and Neck Squamous Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma"
] | 3,782 | 4 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.